5 Hot Biotech Stocks With Fresh Buy Ratings
Analysts initiate coverage with Buy ratings on Sensei (SNSE), Septerna (SEPN), Kazia (KZIA), NervGen (NGEN), and Sutro (STRO).
/ 4 items
#SNSE↓
Sensei Biotherapeutics Gets Wall Street Backing as PIKTOR Advances in Breast & Endometrial Cancer
Cantor is bullish on Sensei Biotherapeutics for its cancer drug PIKTOR, with Phase 2 data soon as a key stock catalyst.
Sensei Buys Faeth & Raises $200 Million to Fight Endometrial & Breast Cancer
Sensei Biotherapeutics acquires Faeth Therapeutics and secures $200M funding to speed up PIKTOR – an easy-to-take pill showing strong early results against hard-to-treat endometrial and breast cancers.
Sensei Biotherapeutics Halts Drug Development, Explores Strategic Options
Sensei Biotherapeutics discontinues solnerstotug development and begins strategic review including potential sale, merger, or wind-down to maximize shareholder value.